Related Experiment Video
Updated: May 20, 2026
09:21
BRET-based G Protein Biosensors for Measuring G Protein-Coupled Receptor Activity in Live Cells
Published on: November 7, 2025
The bioisosteric concept applied to cannabinoid ligands
C Mugnaini1, S Pasquini, F Corelli
1Dipartimento Farmaco Chimico Tecnologico, Universita degli Studi di Siena, Italy.
Current Medicinal Chemistry
|July 27, 2012
Summary
Bioisosterism enhances drug properties by modifying compounds. This review explores bioisosteric substitutions in cannabinoid ligands to improve their effects and how the body processes them.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Bioisosterism is a key strategy in medicinal chemistry for optimizing drug candidates.
- Cannabinoid receptors (CB1 and CB2) are crucial targets for modulating physiological functions.
- Synthetic cannabinoids are developed as selective receptor modulators.
Purpose of the Study:
- To review the application of bioisosteric substitution in designing cannabinoid ligands.
- To highlight how bioisosterism improves pharmacodynamic and pharmacokinetic properties of these ligands.
Main Methods:
- Literature review focusing on bioisosterism in cannabinoid ligand research.
- Analysis of studies detailing modifications of cannabinoid compounds.
- Evaluation of structure-activity relationships influenced by bioisosteric replacements.
Main Results:
- Bioisosteric substitutions offer a rational approach to enhance potency and selectivity of cannabinoid ligands.
- These modifications can significantly improve drug-like properties, including absorption, distribution, metabolism, and excretion (ADME).
- Examples of successful bioisosteric strategies in developing CB1 and CB2 receptor modulators are discussed.
Conclusions:
- Bioisosteric substitution is a valuable tool for optimizing cannabinoid-based therapeutics.
- Strategic use of bioisosterism can lead to improved drug candidates targeting the endocannabinoid system.
- Further exploration of bioisosteric modifications holds promise for novel drug development.
More Related Videos
13:57Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
Related Concept Videos
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...